Single award · contract
Development of CD388 as a Long-Lasting Prophylactic Anti-Viral Option for Protection Against the Health…
Award ID: 75A50125C00017
FY2025 · complete year · data as of 2026-09-01
A single federal award, with both ends of the trail linked.
$58.1M
Total award value
Award 75A50125C00017 is a contract from the Department of Health and Human Services, $58.1M obligated, FY2025 to FY2027, for Development of CD388 as a Long-Lasting Prophylactic Anti-Viral Option for Protection Against the…. The work is performed in California. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN14 (Health R&D Services; Health Care Services; R&D Administrative Expenses). Source
Description
Development of CD388 as a Long-Lasting Prophylactic Anti-Viral Option for Protection Against the Health Impacts Caused by Influenza
Award details
Award typeContract
PIID75A50125C00017
Action date2025
Period24 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceCalifornia →
CategoryNAICS 541714PSC AN14
Competed?Not recordedSource
Total (exact)$58,051,983
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.